Novel anti-prostate cancer scaffold identified by the combination of in silico and cell-based assays targeting the PI3K-AKT-mTOR pathway

Integration of Ligand- and Target-Based Virtual Screening for the Discovery of Cruzain Inhibitors

Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery.